A new era for tumour diagnostics in digital cytology.
AI POWERED DIGITAL CYTOLOGY
Our mission is to make cancer diagnostics objective and scalable with AI, enabling early detection and better patient outcomes.
Our technology advances digital cytology and unlocks a major opportunity in AI-driven healthcare.
THE PROBLEM
Cytology is ripe for disruption to address inefficiencies & enhance precision.
-
Cancer cases are projected to increase from 20 million (2022) to 35 million by 2050 (WHO).
Ageing global population requires more frequent putting pressure on labs.
-
-
High caseloads and reliance on manual interpretation lead to inconsistent diagnoses and errors.
Medical malpractice claims linked to diagnostic errors are rising.
-
Cytologists are required to scroll through multiple layers of slides under a microscope leading to diagnostic errors.
Increased workload and burnout are leading to diagnostic backlogs and delays in patient care.
OUR SOLUTION
-

Early & accurate detection of cancer
– leading to timely treatment and better patient outcomes.
-

Measured parameters & traceability of cells using AI
– less diagnostic discrepancies & ability to historically verify diagnostic conclusions.
-

Faster & precise processing of digital cytology slides
– more patients are assessed accurately with our AI-enhanced decision-making tool.
Led by an experienced team of medical experts in Cytology and AI - including a close collaboration with leading Medical diagnostics company in Europe.
-

Dr. Ondřej Sobek, MD, PhD, MIAC
Co-Founder, Medical Lead, Cytology Expert
It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more.
-

Sanjeevan Bala
Lead of Technology Board, AI Expert
Experienced data and analytics leader and former Group Chief Data & AI Officer at ITV Plc., has spearheaded large-scale digital initiatives across content, production, distribution, and monetization, utilizing his deep expertise in AI applications in healthcare.
-

Milan Prochazka
Co-Founder, Strategy & Investment Expert
Strategic investor with a track record in managing multi-sector investments across healthcare, media, real estate, and energy, leverages his extensive capital markets expertise from emerging markets to scale disruptive health-tech solutions.
-

Jan Dupač, PHD
Technology Development Lead
Jan is PhD with background in computer vision and image analysis both in research and application.

